Sagimet Biosciences (SGMT) Shares Issued (2022 - 2026)

Sagimet Biosciences' Shares Issued history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 45.83% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 45.83% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, up 28.23% from the prior year.
• Shares Issued retreated to $4.0 million in Q1 2026 per SGMT's latest filing, from $5.7 million in the prior quarter.
• Across five years, Shares Issued topped out at $5.7 million in Q2 2025 and bottomed at $1.7 million in Q2 2023.
• The 5-year median for Shares Issued is $3.4 million (2025), against an average of $3.5 million.
• Across the five-year window, Shares Issued grew 17.65% in 2023 and jumped 167.07% in 2024, its largest moves.
• Year by year, Shares Issued stood at $3.2 million in 2022, then advanced by 17.65% to $3.8 million in 2023, then gained by 18.89% to $4.5 million in 2024, then climbed by 28.23% to $5.7 million in 2025, then sank by 30.14% to $4.0 million in 2026.
• Per Business Quant, the three latest SGMT Shares Issued figures stand at $4.0 million (Q1 2026), $5.7 million (Q4 2025), and $3.4 million (Q3 2025).